February 15, 2018
2018 Society of Toxicology (SOT) Annual Meeting
March 11-15, 2018
San Antonio, TX
Visit us at Booth #533.
Monday, March 12, 5:30-7 pm - Ancillary Meeting
Grand Hyatt San Antonio, Republic A-C Room
IIVS Updates and Networking: Updates from Multi-Stakeholder Collaborations to Advance Non-Animal Approaches to Respiratory Toxicology
Speakers: Dr. Warren Casey, Director, NTP Interagency Center for Evaluation of Alternative Toxicological Methods; Amy Clippinger, Director, PETA International Science Consortium Ltd.; Holger Behrsing, Principal Scientist, IIVS
Join us for an evening of refreshments, discussion and updates from IIVS, NICEATM...
August 17, 2017
In 2009, the passing of the Family Smoking Prevention and Tobacco Control Act facilitated the establishment of the FDA Center for Tobacco Products (CTP), and gave it regulatory authority over the marketing, manufacture and distribution of tobacco products, including those termed ‘modified risk’. On April 4-6, 2016, IIVS convened a workshop conference entitled, In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhaled Tobacco Products, to bring together stakeholders representing regulatory agencies, academia and industry to address the research priorities...
April 4, 2017
Presented at SOT 2017...
March 30, 2017
Behrsing H, Raabe H, Manuppello J, et al. Alternatives to Laboratory Animals
March 10, 2017
Check out the recently released special issue of Applied In Vitro Toxicology: Application of In Vitro Toxicology Approaches for the Evaluation of Next-Generation Nicotine Products. The issue includes several articles by IIVS scientists and other experts. View the issue online....
February 20, 2017
Presented at the National Academies of Sciences, Engineering, and Medicine's (NAS) workshop on electronic nicotine delivery systems (ENDS), e-cigarettes....
January 10, 2017
Applied In Vitro Toxicology...
October 18, 2016
This one-hour webinar, led by IIVS Director of Quality and Compliance, introduces some of the concepts of Good Laboratory Practices (GLPs) designed to promote study and data integrity within an in vitro toxicology framework. Applying these concepts within your own laboratory should aid in production of robust, repeatable studies.
August 24, 2016
The Respiratory Toxicology Program utilizes state-of-the-art in vitro and ex-vivo models of pulmonary (and related) tissue. Models available offer a range of testing types, including screening and high content analysis for complex events. The choice of cell line (including reporter cells), primary cells, or 3-dimensional tissues depends on the throughput desired and level of assessment needed. Consider our oral cavity tissues to also model ingestion exposures. Let IIVS guide you to the model best for you!
Pulmonary cell lines are readily...
August 24, 2016
Prolonged exposure of lung tissue to materials, inhaled or otherwise, may challenge the tissue leading to cell death or loss of viability over time. Other changes due to long term exposure or prolonged tissue challenge can manifest in a variety of key events and markers of disease. IIVS’s Respiratory Toxicology Program offers several pulmonary models that will allow the assessment of long term exposure and effects, with cultures that can be maintained for weeks or months.
While assays used for acute toxicity...